PNPLA3 and hepatocellular carcinoma: Furthermore, it was also evident in patients who did not present with advanced or terminal HCC, suggesting that the 148M PNPLA3 allele may be associated with the development of more aggressive HCC, which are not cured or are not amenable to be cured by available therapies.